Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
Add more filters

Publication year range
1.
Folia Phoniatr Logop ; 70(1): 1-7, 2018.
Article in English | MEDLINE | ID: mdl-29847817

ABSTRACT

OBJECTIVE: Bamboo nodes are vocal fold lesions, mostly associated with autoimmune diseases. PATIENTS AND METHODS: This is a retrospective clinical study including 10 patients with bamboo nodes. Data were collected regarding associated autoimmune disorder and type of treatment. A systematic review of the literature was conducted. RESULTS: All patients were women, with hoarseness as the most frequent symptom. There was in most cases an associated autoimmune disease: 3 patients with systemic lupus erythematosus; 3 with rheumatoid arthritis; 1 with Sjögren syndrome; 1 with Hashimoto disease; and 1 with mixed connective tissue disease. Four patients were treated with speech therapy, 3 with oral steroids, 1 with speech therapy and oral steroids combined, 1 with oral steroids and laryngeal steroid injections, and 1 had oral steroids, surgery, and speech therapy. Speech therapy was the first-line treatment. CONCLUSION: Bamboo nodes should be looked for in every patient with a diagnosis of autoimmune disease complaining of dysphonia.


Subject(s)
Autoimmune Diseases/complications , Connective Tissue Diseases/complications , Dysphonia/etiology , Hoarseness/etiology , Laryngeal Diseases/pathology , Vocal Cords/pathology , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Dysphonia/drug therapy , Dysphonia/therapy , Female , Hoarseness/drug therapy , Hoarseness/therapy , Humans , Laryngeal Diseases/drug therapy , Laryngeal Diseases/immunology , Laryngeal Diseases/surgery , Middle Aged , Retrospective Studies , Speech Therapy , Voice Quality , Young Adult
2.
Am J Dermatopathol ; 39(2): e29-e33, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28134738

ABSTRACT

Leishmanides have been rarely reported in the literature. In this study, the authors present a case of a 50-year-old HIV-positive man who developed a generalized cutaneous eruption of papules and plaques in which no microorganism was demonstrated by culture, microscopical examination, immunohistochemistry, or polymerase chain reaction. The patient was eventually diagnosed with laryngeal leishmaniasis, and when treated, the cutaneous lesions greatly improved.


Subject(s)
Immunocompromised Host , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/pathology , HIV Infections/complications , Humans , Laryngeal Diseases/immunology , Laryngeal Diseases/microbiology , Male , Middle Aged
3.
Adv Exp Med Biol ; 905: 69-78, 2016.
Article in English | MEDLINE | ID: mdl-26747066

ABSTRACT

Cough accompanying acute respiratory tract disorders is a self-limiting phenomenon, and it usually does not require sophisticated management. Chronic cough, in contrast, is a bothersome problem, considerably influencing the quality of life of affected individuals. Specialized cough clinics report that substantial proportion of their patients are middle aged-to-postmenopausal females who cough for years in response to otherwise non-tussigenic stimuli, without a clear underlying disease reason. A newly established entity - 'cough hypersensitivity syndrome' explains pathogenesis of this problem. However, the syndrome has not been generally accepted, and the guidelines regarding the diagnostic protocols and treatment are not yet available. The reason why females cough more than males do is unclear, but the analysis of literature and experience with the chronic cough patients allows selecting three main targets of hormonal background which can contribute to the enhanced coughing in females. They are as follows: increased activity of transient receptor potential (TRP) channels expressed on vagal C-fibers mediating cough, laryngeal hypersensitivity and laryngeal dysfunction with paradoxical vocal cord movement, and mast cells which are known to express receptors for female sexual hormones and are frequently found in the bronchoalveolar lavage in chronic cough patients. In this review we analyze the potential contribution of the factors above outlined to excessive cough in female subjects.


Subject(s)
Cough/physiopathology , Laryngeal Diseases/physiopathology , Mast Cells/immunology , Vagus Nerve/physiopathology , Chronic Disease , Cough/immunology , Cough/metabolism , Estrogens/metabolism , Female , Humans , Laryngeal Diseases/immunology , Laryngeal Diseases/metabolism , Mast Cells/metabolism , Nerve Fibers, Unmyelinated/metabolism , Progesterone/metabolism , Sex Factors , Syndrome , Transient Receptor Potential Channels/metabolism , Vagus Nerve/metabolism
4.
Clin Exp Rheumatol ; 33(6 Suppl 94): S123-8, 2015.
Article in English | MEDLINE | ID: mdl-26487319

ABSTRACT

OBJECTIVES: Behçet's disease (BD) is a multisystem autoimmune disease of unknown origin typically affecting the triad of oral and genital mucosa and the eye. Limited data are available in the literature regarding the otolaryngology-related manifestations of BD, particularly in northern Europeans. This is a novel study detailing surprising and significant laryngeal structural changes in a northern European cohort of BD. METHODS: Patients meeting the International Study Group for Behçet's Disease (ISGBD) and the International Criteria for Behçet's Disease (ICBD) criteria for diagnosis were identified from an institutional database. Patients underwent examination with an otolaryngologist, including flexible laryngoscopy. Intra-oral, pharyngeal and laryngeal manifestations of BD were documented and characterised. Patients underwent hearing assessment with pure-tone audiometry. RESULTS: Fifteen patients with BD were identified (4 male, 11 female; median age 36 years). 60% (n=9) showed evidence of disease on examination and flexible laryngoscopy. 33% (n=5) showed laryngeal changes related to BD. 13% (n=2) demonstrated bilateral sensorineural hearing loss. The 5 cases demonstrating laryngeal manifestations of disease are described in detail with photographic records. CONCLUSIONS: Limited data has been published regarding the laryngeal manifestations of BD, particularly in a northern European population. Our cohort of BD patients demonstrate significant laryngeal structural changes. It would appear that these clinically relevant changes may be more common than was previously thought. Raised awareness of the risk of laryngeal pathology in BD patients, often in the absence of overt clinical symptomatology, may result in earlier diagnosis and treatment. Rheumatologists and otolaryngologists should consider closer multi-disciplinary co-operation in the management and follow up of patients with BD.


Subject(s)
Behcet Syndrome/complications , Laryngeal Diseases/etiology , Larynx/pathology , Adult , Aged , Audiometry, Pure-Tone , Behcet Syndrome/diagnosis , Behcet Syndrome/immunology , Behcet Syndrome/therapy , Databases, Factual , Female , Hearing Loss, Bilateral/diagnosis , Hearing Loss, Bilateral/etiology , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/etiology , Humans , Ireland , Laryngeal Diseases/diagnosis , Laryngeal Diseases/immunology , Laryngeal Diseases/therapy , Laryngoscopy , Larynx/immunology , Male , Middle Aged , Predictive Value of Tests , Risk Factors , Young Adult
5.
J Clin Immunol ; 30(6): 823-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20635155

ABSTRACT

INTRODUCTION: Hereditary angioedema (HAE) is a rare disorder characterized by C1 esterase inhibitor (C1-INH) deficiency, resulting in periodic attacks of acute edema that can be life-threatening if they occur in the laryngeal region. We assessed the efficacy of C1-INH concentrate in the emergency treatment of rarely occurring acute laryngeal HAE attacks in a prospective, open-label clinical study. METHODS: Acute laryngeal attacks were each treated with C1-INH concentrate (Berinert) at a single dose of 20 U/kg body weight. Efficacy endpoints included time to onset of symptom relief and time to complete resolution of all symptoms, each based on the patient's assessment. RESULTS: All 39 laryngeal attacks in 16 patients were treated successfully. The median time to onset of symptom relief was 15 min. The median time to complete resolution of all symptoms was 8.25 h. No treatment-related serious adverse events occurred, and the treatment was well tolerated. The administration of C1-INH concentrate was not associated with any viral infections. CONCLUSION: C1-INH concentrate is an effective and safe emergency treatment for providing reliable and rapid relief from the potentially life-threatening symptoms of laryngeal HAE attacks.


Subject(s)
Angioedemas, Hereditary/drug therapy , Complement C1 Inhibitor Protein/administration & dosage , Laryngeal Diseases/drug therapy , Adolescent , Adult , Angioedemas, Hereditary/genetics , Angioedemas, Hereditary/immunology , Angioedemas, Hereditary/physiopathology , Complement C1 Inhibitor Protein/adverse effects , Complement C1 Inhibitor Protein/genetics , Disease-Free Survival , Edema , Emergency Medical Services , Feasibility Studies , Female , Humans , Laryngeal Diseases/genetics , Laryngeal Diseases/immunology , Laryngeal Diseases/physiopathology , Male , Middle Aged , Prospective Studies , Surveys and Questionnaires
6.
Auris Nasus Larynx ; 47(4): 706-710, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31337521

ABSTRACT

Voice disorder is occasionally associated with systemic autoimmune diseases. Bamboo nodes of the vocal fold have a characteristic bamboo-shaped appearance and strongly indicate the presence of an underlying autoimmune disorder. Both mechanical and immunologic mechanisms are assumed to be involved in the pathogenesis of vocal disorder. We present a 27-year-old woman with hoarseness, sore throat, and a unilateral bamboo node of the vocal fold. Serum anti-SS-A and -SS-B antibodies were positive, but she had no systemic signs or symptoms suggestive of Sjögren's syndrome. Oral systemic glucocorticoid treatment was not effective, but surgical resection improved her hoarseness. Histopathologic findings of the resected vocal node revealed fibrosis with hyaline degeneration. Thereafter, she had no recurrence of hoarseness for 2 years. Bamboo nodes of the vocal fold may occur without definitive autoimmune diseases, although immunologic abnormalities such as autoantibody-positivity may occur.


Subject(s)
Antibodies, Antinuclear/immunology , Hoarseness/immunology , Laryngeal Diseases/immunology , Vocal Cords/surgery , Adult , Connective Tissue Diseases/immunology , Female , Hoarseness/etiology , Hoarseness/physiopathology , Humans , Laryngeal Diseases/pathology , Laryngeal Diseases/physiopathology , Laryngeal Diseases/surgery , Laryngoscopy , Pharyngitis/etiology , Pharyngitis/immunology , Pharyngitis/physiopathology , Vocal Cords/pathology , Voice Disorders/etiology , Voice Disorders/physiopathology
7.
Article in Portuguese | MEDLINE | ID: mdl-39052027

ABSTRACT

The literature holds few descriptions on immune response findings for laryngeal cryptococcosis. Immunology has been more extensively described in cases involving the central nervous system and the lungs, although many of these studies were conducted in animal models. We aimed to analyze the clinical and immunological characteristics of three patients with laryngeal cryptococcosis. We observed a weak participation of the innate immune response, whereas adaptive immunity showed the predominance of a Th2-type response over a Th1-type response. Most cases occur in male older adults with immunosuppressive conditions, of which HIV infection was absent. Hoarseness configured the main symptom. We found a disease that was restricted to the larynx and possibly the lungs by contiguity. Patients with hoarseness and lesions in nasal endoscopy should be investigated for cryptococcosis by a biopsy of the larynx, including with negative serum cryptococcal antigen. The immunological aspects of our findings of laryngeal involvement resembled those in the most commonly affected systems.


Subject(s)
Cryptococcosis , Laryngeal Diseases , Humans , Cryptococcosis/immunology , Laryngeal Diseases/immunology , Laryngeal Diseases/microbiology
8.
J Voice ; 33(3): 357-362, 2019 May.
Article in English | MEDLINE | ID: mdl-29242051

ABSTRACT

OBJECTIVES: Bamboo nodes are band-like submucosal deposits of the middle third of the vocal fold. They are often related to connective tissue disorders, but can also precede them. The aim of this study was to report our experience with conservative treatment of those rare lesions. METHODS: This is a retrospective series of 15 patients consulting for hoarseness and presenting bamboo nodes from 2010 to 2016. RESULTS: All patients were women of mean age of 38 years with a moderate or high degree of daily vocal effort. Nine patients (60%) presented with known autoimmune disease at the phoniatric appointment. The other patients (40%) benefited from a systematic biological research for autoimmune disease, which retrieved two poorly symptomatic connective tissue disorders. Patients were clinically improved by speech therapy (53%) or by an optimization or introduction of immunosuppressive treatment (46%). A spontaneous improvement was observed for three patients after voice rest (one after retirement, one after professional change, and last one after resuming professional singing). In our series, no phonosurgery was performed. The vocal profile at last appointment found a moderate Voice Handicap Index at 35.3/120, a low maximum time of phonation at 13.6 seconds, and a high jitter at 1.4, sign of instability of the vibrator. CONCLUSION: This series emphasizes the importance of diagnosing bamboo nodes in middle-aged female presenting an autoimmune disease. Vice versa for each patient with bamboo nodes, a systematic autoimmune check-up has to be realized to detect a biological asymptomatic autoimmune disease.


Subject(s)
Autoimmune Diseases/pathology , Hoarseness/pathology , Laryngeal Diseases/pathology , Vocal Cords/pathology , Autoimmune Diseases/immunology , Autoimmune Diseases/physiopathology , Autoimmune Diseases/therapy , Hoarseness/immunology , Hoarseness/physiopathology , Hoarseness/therapy , Humans , Immunosuppressive Agents/therapeutic use , Laryngeal Diseases/immunology , Laryngeal Diseases/physiopathology , Laryngeal Diseases/therapy , Laryngoscopy , Paris , Phonation , Recovery of Function , Retrospective Studies , Speech Therapy , Treatment Outcome , Vocal Cords/immunology , Vocal Cords/physiopathology , Voice Quality
9.
Curr Opin Allergy Clin Immunol ; 8(1): 28-33, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18188014

ABSTRACT

PURPOSE OF REVIEW: Laryngopharyngeal reflux is a well-recognized and widely used term in ear, nose and throat practice. However, the symptoms and signs attributed to laryngopharyngeal reflux are non-specific and treatment is usually empirical. This review discusses current knowledge on diagnosis and treatment of laryngopharyngeal reflux. RECENT FINDINGS: Information is evolving regarding the implications of laryngopharyngeal reflux in the development of pathological conditions affecting the upper aerodigestive tract epithelium such as chronic laryngitis, otitis media with effusion and chronic sinusitis. However, there is still much to learn about the pathophysiologic mechanisms of laryngopharyngeal reflux and their role in its related disease conditions and there is still considerable controversy on diagnostic as well as therapeutic parameters for this condition. There is no consensus on the diagnosis and treatment of laryngopharyngeal reflux and the majority of clinicians depend mainly on clinical findings and empirical therapeutic tests rather than more specific investigations. SUMMARY: The concept of laryngopharyngeal reflux is still controversial. The current practice of empirical treatment with proton-pump inhibitors is based on weak evidence. However, this practice seems to be widely accepted and will not change until further clinical and laboratory studies improve our understanding of this common and well-recognized condition.


Subject(s)
Hypopharynx/pathology , Laryngeal Diseases/diagnosis , Laryngeal Diseases/pathology , Laryngeal Diseases/therapy , Chronic Disease , Esophageal Sphincter, Lower/pathology , Esophageal Sphincter, Upper/pathology , Esophageal pH Monitoring , Feeding Behavior , Gastric Acid/metabolism , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/pathology , Gastroesophageal Reflux/physiopathology , Gastroesophageal Reflux/therapy , Histamine H2 Antagonists/therapeutic use , Humans , Hypopharynx/immunology , Laryngeal Diseases/immunology , Laryngeal Diseases/physiopathology , Laryngoscopy , Life Style , Pharyngeal Diseases/diagnosis , Pharyngeal Diseases/immunology , Pharyngeal Diseases/pathology , Pharyngeal Diseases/therapy , Proton Pump Inhibitors/therapeutic use
10.
Clin Rheumatol ; 37(4): 1075-1083, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29460094

ABSTRACT

Ear, nose and throat (ENT) manifestations in granulomatosis with polyangiitis (GPA) represent the most frequent symptoms at disease onset. The aim of the study was to analyse ENT involvement at diagnosis, as well as how it could influence relapse rate, mortality and disease severity. A retrospective non-controlled cohort study was performed including all consecutive diagnosed GPA from 1996 to 2016 in two rheumatology centres of Northern Italy, focusing particularly on ENT presenting signs and symptoms at baseline. Eighty-nine patients (48.3% females) with new onset GPA were evaluated. They were mostly Caucasian (97.7%), middle aged (mean 54.5 years) and more frequently anti-neutrophil cytoplasmic antibodies (ANCA) positive (78.6%) with PR3 specificity (81.4%). At diagnosis, ENT involvement was reported in 71.9% patients, second only to systemic symptoms. These patients were significantly younger at disease onset (0.013), with less frequent renal involvement (0.014) irrespectively to ANCA status, but with significantly higher Vasculitis Damage Index (VDI) (0.001). The most frequent ENT manifestation was sinonasal involvement (58.4%, 73% of which with nasal inflammation/chronic sinusitis and 48% with nasal crusting), while otologic involvement (mainly otitis media/otomastoiditis) was observed in 34.8%. ENT-GPA patients presented a higher survival rate at 5 years (98.1 vs 77.7%, 0.049), and ENT involvement resulted to be an independent predictor of better outcome (OR 0.37, 95% CI 0.2-0.8, 0.019). Our data confirms that ENT involvement is not only one of the key clinical features of GPA, but also could point out a milder GPA subset with lower renal involvement and lower mortality rate, irrespectively to ANCA status.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/immunology , Ear Diseases/etiology , Granulomatosis with Polyangiitis/complications , Laryngeal Diseases/etiology , Paranasal Sinus Diseases/etiology , Adult , Aged , Ear Diseases/immunology , Ear Diseases/physiopathology , Female , Granulomatosis with Polyangiitis/immunology , Granulomatosis with Polyangiitis/physiopathology , Humans , Laryngeal Diseases/immunology , Laryngeal Diseases/physiopathology , Male , Middle Aged , Paranasal Sinus Diseases/immunology , Paranasal Sinus Diseases/physiopathology , Retrospective Studies
11.
BMJ Case Rep ; 20182018 Jun 20.
Article in English | MEDLINE | ID: mdl-29930164

ABSTRACT

Plasma cell mucositis (PCM) is a rare non-neoplastic plasma cell proliferative disorder of the mucous membranes, which typically presents as soft tissue lesions involving oral, upper airway or genital mucosa. Laryngeal involvement resulting in stridor has been reported in four other cases previously, with three requiring tracheostomy. We present a case of supraglottic stenosis in a 53-year-old woman presenting with dysphonia and stridor, requiring surgical resection on three occasions accompanied by tracheostomy on two occasions; biopsy was consistent with PCM. Due to relapsing disease activity, high-dose prednisolone and mycophenolate mofetil were commenced with prednisolone eventually being ceased. After 2 years of mycophenolate mofetil therapy, the patient's disease has been controlled without need for further surgical intervention. This is the first reported case of prolonged symptomatic improvement with the use of systemic immunosuppressive therapy with mycophenolate mofetil in PCM.


Subject(s)
Immunosuppression Therapy/methods , Immunosuppressive Agents/administration & dosage , Laryngeal Diseases/drug therapy , Mucositis/drug therapy , Plasma Cells/immunology , Drug Administration Schedule , Female , Humans , Laryngeal Diseases/immunology , Laryngeal Mucosa/cytology , Laryngeal Mucosa/immunology , Middle Aged , Mucositis/immunology , Mycophenolic Acid/administration & dosage , Prednisolone/administration & dosage , Respiratory Sounds/etiology , Time , Time Factors
12.
Laryngoscope ; 127(12): 2827-2829, 2017 12.
Article in English | MEDLINE | ID: mdl-28771743

ABSTRACT

Prior to the onset of the antibiotic era, laryngeal perichondritis and abscess formation were more frequent complications of systemic infections. We report a case of 54-year-old male who was medically immunosuppressed after kidney transplantation and developed multiple pseudomonas abscesses of his larynx. After failing initial treatment and with worsening signs and symptoms, the patient eventually was treated with a prolonged course of intravenous and oral antibiotics, with resolution of his symptoms and clinical findings. Although this pathophysiology remains uncommon, laryngeal abscess formation should remain in the differential for persistent symptoms, especially in cases of patients on immunosuppression. Laryngoscope, 127:2827-2829, 2017.


Subject(s)
Abscess/immunology , Immunocompromised Host , Laryngeal Diseases/immunology , Pseudomonas Infections/immunology , Abscess/diagnosis , Abscess/drug therapy , Humans , Laryngeal Diseases/diagnosis , Laryngeal Diseases/drug therapy , Male , Middle Aged , Pseudomonas Infections/diagnosis , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa
13.
Medicine (Baltimore) ; 85(4): 239-252, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16862049

ABSTRACT

We conducted a prospective study between 1995 and 2002 to investigate nose and throat (NT) manifestations of mucous membrane pemphigoid (MMP). One hundred ten consecutive patients with clinical, histologic, and immunologic criteria of MMP were seen in 2 referral centers for bullous diseases. They were systematically asked about the existence of persistent NT symptoms. Patients who had any were examined with a flexible nasopharyngolaryngoscope by the same otorhinolaryngologist. When possible, NT mucous membrane (MM) biopsies were taken for direct immunofluorescence (IF) assays to determine lesion specificity. Thirty-eight (35%) patients (23 F/15 M; mean age, 58.5 yr) had the following NT symptoms: 35 (92%) nasal, 19 (50%) pharyngeal, and 10 (26%) laryngeal. Five (13%) had acute dyspnea. Thirty-three (87%) of the 38 symptomatic patients had lesions at physical examination: 30 (79%) nasal, 6 (16%) pharyngeal, and 19 (50%) laryngeal. Laryngeal involvement was asymptomatic in 11 patients. Lesions were mainly atrophic rhinitis and oropharyngeal and epiglottal erosions. Nasal valves, choanae, pharynx, and/or larynx were severely scarred in 7 (18%) patients, causing the death of 3. Direct IF showed malpighian epithelium associated with linear immune deposits (IgG, IgA, or C3) along the chorioepithelial junction in all 18 biopsies performed, including those of 4 symptomatic patients without lesions at physical examination. The presence of severe ophthalmologic lesions (p = 0.02) and > or =3 sites involved other than NT (p = 0.02) were predictive of laryngeal involvement. In contrast, laryngeal symptoms, disease duration, HLA DQB1*0301, and smoking were not significantly associated with laryngeal lesions. In conclusion, at least 35% of MMP patients had NT involvement. Atrophic rhinitis was the most frequent lesion. The most severe were the laryngeal lesions that were significantly associated with severe ocular involvement and disseminated disease, and could be fatal. Our results highlight the necessity of a multidisciplinary approach to MMP management to assure early diagnosis of NT involvement, to guide therapeutic choices, and to improve patient survival and functional outcomes.


Subject(s)
Laryngeal Diseases/etiology , Nose Diseases/etiology , Pemphigoid, Benign Mucous Membrane/complications , Pharyngeal Diseases/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Endoscopy , Female , Humans , Immunoenzyme Techniques , Laryngeal Diseases/immunology , Laryngeal Diseases/pathology , Male , Middle Aged , Nose Diseases/immunology , Nose Diseases/pathology , Pemphigoid, Benign Mucous Membrane/immunology , Pemphigoid, Benign Mucous Membrane/pathology , Pharyngeal Diseases/immunology , Pharyngeal Diseases/pathology , Prospective Studies , Tomography, X-Ray Computed
15.
Curr Opin Allergy Clin Immunol ; 15(2): 150-5, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25961388

ABSTRACT

PURPOSE OF REVIEW: The purpose of this study is to review the relevant literature concerning work-associated irritable larynx syndrome (WILS), a hyperkinetic laryngeal disorder associated with occupational irritant exposure. Clinical symptoms are variable and include dysphonia, cough, dyspnoea and globus pharyngeus. WILS is a clinical diagnosis and can be difficult to differentiate from asthma. Treatment options for WILS include medical and behavioural therapy. RECENT FINDINGS: Laryngeal-centred upper airway symptoms secondary to airborne irritants have been documented in the literature under a variety of diagnostic labels, including WILS, vocal cord dysfunction (VCD), laryngeal hypersensitivity and laryngeal neuropathy and many others. The underlying pathophysiology is as yet poorly understood; however, the clinical scenario suggests a multifactorial nature to the disorder. More recent literature indicates that central neuronal plasticity, inflammatory processes and psychological factors are all likely contributors. SUMMARY: Possible mechanisms for WILS include central neuronal network plasticity after noxious exposure and/or viral infection, inflammation (i.e. reflux disease) and intrinsic patient factors such a psychological state. Treatment is individualized and frequently includes one or more of the following: environmental changes in the workplace, GERD therapy, behavioural/speech therapy, psychotherapy counselling and neural modifiers.


Subject(s)
Laryngeal Diseases , Occupational Diseases , Occupational Exposure/adverse effects , Humans , Laryngeal Diseases/etiology , Laryngeal Diseases/immunology , Laryngeal Diseases/pathology , Laryngeal Diseases/psychology , Occupational Diseases/immunology , Occupational Diseases/pathology , Occupational Diseases/psychology , Syndrome
16.
Arch Otolaryngol Head Neck Surg ; 128(12): 1420-3, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12479732

ABSTRACT

A case of antiepiligrin cicatricial pemphigoid that primarily involved the larynx and required a tracheostomy was studied. The diagnosis was based on the direct immunofluorescence findings of a biopsy specimen from the glottis, immunofluorescence using normal and 1M sodium chloride-split normal human skin as substrates, and immunoprecipitation. A dramatic clinical improvement was observed after the combined administration of tetracycline hydrochloride and niacinamide. The tracheal stoma could be shut after the narrow segment was cut by means of carbon dioxide laser therapy. The patient showed no respiratory difficulty during the 2-year follow-up period. The combined therapy of tetracycline and niacinamide is thus considered to be an effective treatment for various types of cicatricial pemphigoid.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Laryngeal Diseases/drug therapy , Niacinamide/therapeutic use , Pemphigoid, Benign Mucous Membrane/drug therapy , Aged , Aged, 80 and over , Cell Adhesion Molecules/immunology , Drug Combinations , Humans , Laryngeal Diseases/immunology , Laryngostenosis/drug therapy , Laryngostenosis/immunology , Laryngostenosis/surgery , Male , Pemphigoid, Benign Mucous Membrane/immunology , Pemphigoid, Benign Mucous Membrane/surgery , Tetracyclines , Tracheostomy , Kalinin
17.
Otolaryngol Head Neck Surg ; 113(1): 147-50, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7603711

ABSTRACT

Two unique cases of rheumatoid nodules affecting the larynx are reported. These subcutaneous nodules represent localized laryngeal involvement from autoimmune disorders. The otolaryngologist should be aware of these possibilities as part of the differential diagnosis in the workup of dysphonia.


Subject(s)
Laryngeal Diseases/immunology , Rheumatoid Nodule/immunology , Adult , Arthritis, Rheumatoid/complications , Female , Hoarseness/etiology , Humans , Laryngeal Diseases/diagnosis , Laryngeal Diseases/pathology , Laryngeal Diseases/surgery , Laryngoscopy , Lupus Erythematosus, Systemic/complications , Middle Aged , Rheumatoid Nodule/diagnosis , Rheumatoid Nodule/pathology , Rheumatoid Nodule/surgery
18.
Otolaryngol Head Neck Surg ; 106(4): 372-7, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1565488

ABSTRACT

The clinical nature of laryngeal amyloidosis has not been well established, and the natural history of the disease remains a controversial matter. To address these issues, we reviewed the clinicopathologic and immunohistochemical features of 22 cases (11 men and 11 women; mean age, 56 years) of laryngeal amyloidosis. Hoarseness was the most common symptom, and the most frequent site affected was the false vocal cords. Six patients had concomitant tracheal amyloidosis. Paraffin blocks were available for immunostaining in 20 cases. Nineteen cases were positive for amyloid P component. lambda-Light chains were detected in 12 cases and kappa-light chains in 5; three cases did not show definite light-chain staining. Ten patients underwent repeated operations for persistent or recurrent respiratory tract disease. One patient died of progressive tracheobronchial amyloidosis, but systemic amyloidosis did not develop in any of the patients. Laryngeal amyloidosis is a form of localized amyloidosis characterized by monoclonal light-chain deposition. Recurrent respiratory tract disease is not uncommon, but the usual clinical course is relatively benign.


Subject(s)
Amyloidosis , Laryngeal Diseases , Adult , Aged , Amyloid/metabolism , Amyloidosis/diagnosis , Amyloidosis/immunology , Amyloidosis/pathology , Female , Follow-Up Studies , Humans , Immunoglobulin gamma-Chains/analysis , Immunoglobulin kappa-Chains/analysis , Immunohistochemistry , Laryngeal Diseases/diagnosis , Laryngeal Diseases/immunology , Laryngeal Diseases/pathology , Larynx/immunology , Larynx/metabolism , Male , Middle Aged
20.
Ann Otol Rhinol Laryngol ; 102(11): 884-9, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8239352

ABSTRACT

We report the biochemical characterization of amyloid fibrils from a patient with localized amyloidosis of the epiglottis and larynx. Biopsy specimens showed amorphous material consistent with amyloid deposits with a plasmacytic infiltrate. Both plasma cells and amyloid deposits stained positively by immunohistochemistry for kappa light chains. Amyloid fibrils were isolated. The major constituent resolved as a 13 kd band was sequenced and found to be consistent with a kappa 1 light chain. A tryptic digest was carried out and 3 tryptic peptides were sequenced defining the first 45 residues of the protein and residues 110 through 119. Four amino acid substitutions were found, 3 of which have not been described previously. This study defines the immunoglobulin origin of amyloid deposits in localized amyloidosis. The benign nature of localized amyloidosis suggests that a localized clone of plasma cells producing an amyloidogenic light chain may represent the pathogenetic mechanism of this disease, which appears to be a form of plasma cell dyscrasia.


Subject(s)
Amyloidosis/immunology , Immunoglobulin kappa-Chains/analysis , Laryngeal Diseases/immunology , Amino Acid Sequence , Amyloid/analysis , Amyloidosis/diagnostic imaging , Amyloidosis/metabolism , Amyloidosis/pathology , Electrophoresis, Polyacrylamide Gel , Female , Humans , Laryngeal Diseases/diagnostic imaging , Laryngeal Diseases/metabolism , Laryngeal Diseases/pathology , Larynx/immunology , Middle Aged , Molecular Sequence Data , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL